LAD:NYSELithia Motors, Inc. Analysis
Data as of 2026-04-14 - not real-time
$279.06
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Lithia Motors (LAD) is trading at $279.06, just below its 50‑day SMA of $278.88 and near the $280.28 resistance level, with a 14‑day RSI of 64 indicating modest overbought pressure. The MACD histogram is positive (+4.86) and the signal is bullish, yet volume is on a decreasing trend and the 30‑day volatility is elevated at 28%, supporting a short‑term bearish bias. Fundamentally, the stock sports a low trailing PE of 8.6, a price‑to‑book near parity (0.99), and a price‑to‑sales of 0.17, suggesting it is undervalued relative to peers. The dividend yield of 0.81% is backed by a very low payout ratio of 6.7%, making the payout appear sustainable despite a high debt‑to‑equity ratio.
Recent acquisitions of Toyota of Gallatin and Mercedes‑Benz of Medford have added $225 million in annualized U.S. revenue, reinforcing the company's growth narrative. The buy rating from 15 analysts (median target $376) and bullish commentary from billionaire David Abrams add credibility to the upside potential of roughly 33%. While the consumer‑cyclical sector remains sensitive to economic cycles, LAD’s diversified financing operations and strong free cash flow provide a cushion. Overall, the blend of attractive valuation, strategic acquisitions, and dividend safety points to a buy stance for medium‑ to long‑term horizons, with a cautious hold in the immediate term.
Recent acquisitions of Toyota of Gallatin and Mercedes‑Benz of Medford have added $225 million in annualized U.S. revenue, reinforcing the company's growth narrative. The buy rating from 15 analysts (median target $376) and bullish commentary from billionaire David Abrams add credibility to the upside potential of roughly 33%. While the consumer‑cyclical sector remains sensitive to economic cycles, LAD’s diversified financing operations and strong free cash flow provide a cushion. Overall, the blend of attractive valuation, strategic acquisitions, and dividend safety points to a buy stance for medium‑ to long‑term horizons, with a cautious hold in the immediate term.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price flirting with resistance and overbought RSI
- Decreasing volume and high short‑term volatility
- Bearish trend direction despite bullish MACD signal
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Undervalued valuation multiples (PE, P/B, P/S)
- Acquisition‑driven revenue boost and strong analyst targets
- Sustainable dividend with low payout ratio
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Strategic expansion and diversified financing operations
- Long‑term upside potential of >30% to consensus price target
- Resilient cash flow generation despite high leverage
Key Metrics & Analysis
Financial Health
Revenue Growth0.30%
Profit Margin2.18%
P/E Ratio8.6
ROE12.42%
ROA4.22%
Debt/Equity235.16
P/B Ratio1.0
Op. Cash Flow$356.7M
Free Cash Flow$774.4M
Technical Analysis
TrendBearish
RSI64.0
Support$239.78
Resistance$280.28
MA 20$255.50
MA 50$278.88
MA 200$310.97
MACDBullish
VolumeDecreasing
Fear & Greed Index87.29
Valuation
Target Price$370.73
Upside/Downside32.85%
GradeUndervalued
TypeValue
Dividend Yield0.81%
Risk Assessment
Beta1.09
Volatility28.21%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.